15 Best Selling Most Profitable Drugs of All Time

Page 11 of 16

6. Enbrel

Enbrel is used to treat autoimmune diseases. The drug inhibits the tumor necrosis factor (TNG). The FDA has approved this drug for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. Amgen, Inc. (NASDAQ:AMGN) acquired the selling rights to Enbrel from Immunex in 2002. Amgen has the right to sell Enbrel in the U.S and Canada, while the drug is sold by Pfizer elsewhere. As of the end of 2016, Enbrel’s total sales were $77.2 billion.

bogdanhoda/Shutterstock.com

bogdanhoda/Shutterstock.com

Page 11 of 16